Phase
Condition
Allergy
Scalp Disorders
Eczema (Atopic Dermatitis - Pediatric)
Treatment
N/AClinical Study ID
Ages > 12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Capable of understanding and willing to provide signed informed consent
Male or female at least 12 years of age at time of consent and at time of first dose.
Able to complete the study and to comply with study instructions.
Moderate to severe hand dermatitis.
Chronic hand dermatitis diagnosis must be at least 6 months
Exclusion
Exclusion Criteria:
Female who is pregnant, trying to become pregnant, or breast feeding.
Currently diagnosed with allergic contact dermatitis.
Participated in a previous study of the same study product.
Had any major illness within 30 days before the screening/baseline visit.
Considered immunocompromised.
Has a clinically relevant history of or current evidence of abuse of alcohol or otherdrugs.
Considered unable or unlikely to attend the necessary visits.
Study Design
Study Description
Connect with a study center
GSK Investigational Site
San Diego, California 92123
United StatesSite Not Available
GSK Investigational Site
Boynton Beach, Florida 33437
United StatesSite Not Available
GSK Investigational Site
West Palm Beach, Florida 33401
United StatesSite Not Available
GSK Investigational Site
Louisville, Kentucky 40217
United StatesSite Not Available
GSK Investigational Site
Belleville, New Jersey 07109
United StatesSite Not Available
GSK Investigational Site
Montclair, New Jersey 07042
United StatesSite Not Available
GSK Investigational Site
Knoxville, Tennessee 37922
United StatesSite Not Available
GSK Investigational Site
Nashville, Tennessee 37215
United StatesSite Not Available
GSK Investigational Site
Austin, Texas 78759
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.